Kate White, CFRE, currently serves as the Director of Philanthropy and Corporate Partnerships at Cystic Fibrosis Canada since January 2022, where strategic leadership is provided to align revenue portfolios and drive growth in corporate partnerships through innovative fundraising strategies. Prior to this role, Kate was the Director of Development at the Canadian Down Syndrome Society, overseeing a diverse national fundraising portfolio, and held interim leadership as Director of Events at Sinai Health Foundation. Additional experience includes directing fundraising initiatives at Childhood Cancer Canada Group, achieving significant revenue goals at Heart & Stroke, and managing operations at Diabetes Canada and Sitel. Educational background includes studies at Ryerson University and Brock University.
This person is not in any teams
Cystic Fibrosis Canada / Fibrose kystique Canada
Cystic Fibrosis Canada is a national not-for-profit corporation and one of the world’s top three charitable organizations committed to improving and lengthening the lives of people living with cystic fibrosis. In our 60 year history, we have advanced cystic fibrosis research and care that has more than doubled life expectancy for Canadians living with cystic fibrosis. We’ve contributed to the global body of CF knowledge, funding research achievements such as mapping the gene that causes cystic fibrosis, in 1989. And we’ve advanced access to life-changing CF medicines in Canada through relentless advocacy and government relations work. Today, CF Canada is a leading organization with a central role engaging people living with cystic fibrosis, parents and caregivers, volunteers, researchers and healthcare professionals, government and donors. We work together to change lives through treatments, research, information and support. * Fibrose kystique Canada sommes un organisme de bienfaisance national à but non lucratif et l’un des trois principaux organismes de bienfaisance au monde voués à l’amélioration et au prolongement de la vie des personnes fibro-kystiques. Au cours de nos 60 ans d’histoire, nos avancées dans les domaines de la recherche et des soins ont plus que doublé l’espérance de vie des Canadiens fibro-kystiques. Nous avons contribué à l’ensemble des connaissances mondiales sur la FK et financé des réalisations en recherche, notamment la cartographie du gène responsable de la fibrose kystique en 1989. Nous avons également fait progresser l’accès aux médicaments révolutionnaires contre la FK au Canada, grâce à notre travail constant de défense des droits et de relations avec les gouvernements. Aujourd’hui, FK Canada est un leader quant à l’engagement des personnes touchées par la maladie : celles qui vivent avec la maladie, les parents, les aidants, les bénévoles, les chercheurs et les professionnels de la santé, les gouvernements et les donateu